ES2169881T3 - Nuevos derivados de amida de pirrolidina sustituidos con heterociclo. - Google Patents

Nuevos derivados de amida de pirrolidina sustituidos con heterociclo.

Info

Publication number
ES2169881T3
ES2169881T3 ES97946443T ES97946443T ES2169881T3 ES 2169881 T3 ES2169881 T3 ES 2169881T3 ES 97946443 T ES97946443 T ES 97946443T ES 97946443 T ES97946443 T ES 97946443T ES 2169881 T3 ES2169881 T3 ES 2169881T3
Authority
ES
Spain
Prior art keywords
pirrolidine
heterociclo
substituted
new
amid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97946443T
Other languages
English (en)
Inventor
Thimothy P Burkholder
George D Maynard
Elizabeth M Kudlacz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2169881T3 publication Critical patent/ES2169881T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS AMIDAS DERIVADAS DE LA PIRROLIDINA, CON SUSTITUTO HETEROCICLICO, QUE TIENEN LA FORMULA (1), SUS ESTEREOISOMEROS Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, ASI COMO AL USO DE ESTOS COMPUESTOS COMO ANTAGONISTAS DE LOS RECEPTORES DE LA TAQUIQUININA. ESTOS ANTAGONISTAS SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES Y DE TRASTORNOS ASOCIADOS CON LA TAQUIQUININA, EN ESPECIAL EL ASMA, LA TOS Y LA BRONQUITIS.
ES97946443T 1996-12-19 1997-11-03 Nuevos derivados de amida de pirrolidina sustituidos con heterociclo. Expired - Lifetime ES2169881T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76981296A 1996-12-19 1996-12-19

Publications (1)

Publication Number Publication Date
ES2169881T3 true ES2169881T3 (es) 2002-07-16

Family

ID=25086573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97946443T Expired - Lifetime ES2169881T3 (es) 1996-12-19 1997-11-03 Nuevos derivados de amida de pirrolidina sustituidos con heterociclo.

Country Status (21)

Country Link
EP (1) EP0946548B1 (es)
JP (1) JP4195512B2 (es)
KR (1) KR100514263B1 (es)
CN (1) CN1119344C (es)
AR (1) AR009665A1 (es)
AT (1) ATE214063T1 (es)
AU (1) AU723966B2 (es)
BR (1) BR9714057A (es)
CA (1) CA2275527C (es)
DE (1) DE69710921T2 (es)
DK (1) DK0946548T3 (es)
ES (1) ES2169881T3 (es)
HK (1) HK1020947A1 (es)
HU (1) HUP0000315A3 (es)
IL (1) IL130223A (es)
NO (1) NO317760B1 (es)
NZ (1) NZ335975A (es)
PT (1) PT946548E (es)
TW (1) TW486477B (es)
WO (1) WO1998027086A1 (es)
ZA (1) ZA9711271B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
IL158990A0 (en) * 2001-07-20 2004-05-12 Pfizer Prod Inc Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
ATE519738T1 (de) 2007-08-22 2011-08-15 Hoffmann La Roche Pyrrolidinarylether als nk3-rezeptorantagonisten
AU2019373306A1 (en) 2018-10-29 2021-04-08 Boehringer Ingelheim International Gmbh Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1994026735A1 (en) * 1993-05-06 1994-11-24 Merrell Dow Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
WO1997019074A1 (en) * 1995-11-17 1997-05-29 Hoechst Marion Roussel, Inc. Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases

Also Published As

Publication number Publication date
EP0946548A1 (en) 1999-10-06
IL130223A (en) 2005-09-25
NZ335975A (en) 2000-11-24
DE69710921T2 (de) 2002-09-19
NO993013L (no) 1999-08-18
BR9714057A (pt) 2000-05-09
ZA9711271B (en) 1998-06-19
IL130223A0 (en) 2000-06-01
JP2001506650A (ja) 2001-05-22
HK1020947A1 (en) 2000-05-26
HUP0000315A3 (en) 2002-01-28
NO993013D0 (no) 1999-06-18
CA2275527C (en) 2003-09-23
DE69710921D1 (de) 2002-04-11
HUP0000315A2 (hu) 2001-04-28
KR100514263B1 (ko) 2005-09-15
WO1998027086A1 (en) 1998-06-25
ATE214063T1 (de) 2002-03-15
JP4195512B2 (ja) 2008-12-10
AU5160798A (en) 1998-07-15
CN1241185A (zh) 2000-01-12
DK0946548T3 (da) 2002-06-24
PT946548E (pt) 2002-06-28
NO317760B1 (no) 2004-12-13
AR009665A1 (es) 2000-04-26
EP0946548B1 (en) 2002-03-06
CN1119344C (zh) 2003-08-27
TW486477B (en) 2002-05-11
AU723966B2 (en) 2000-09-07
CA2275527A1 (en) 1998-06-25
KR20000057668A (ko) 2000-09-25

Similar Documents

Publication Publication Date Title
PA8547901A1 (es) Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6
HN1998000157A (es) Agonistas de prostaglandinas
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
BR0114630A (pt) Secretagogos de hormÈnio do crescimento
CR20120007A (es) 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
ECSP941135A (es) Antagonistas triciclicos de vasopresina de benzacepina
PA8546601A1 (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6
UY26086A1 (es) Procedimientos e intermedios para preparar compuestos anticancerosos
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
UY28026A1 (es) 4-piperazinilbencenosulfonilindoles y usos de los mismos.
ES2188957T3 (es) N-(4-(heteroarilmetil)fenil)-heteroarilaminas.
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
ES2179353T3 (es) Antagonistas muscarinicos.
UY26919A1 (es) Derivados de la quinazolina como antagonistas adrenérgicos alfa - 1
UY27232A1 (es) Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos
PA8487701A1 (es) Derivados de 3,3-biarilpiperidina y 2,2-biarilmorfolina
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
ES2157524T3 (es) Diselenuros y selenosulfuros utilizables como agentes antioxidantes.
ATE243209T1 (de) Tetrahydro gamma-carboline
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2169881T3 (es) Nuevos derivados de amida de pirrolidina sustituidos con heterociclo.
ES2152682T3 (es) Derivados de indolina utiles como antagonistas del receptor 5ht-2c.
FI905957A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
ES2162686T3 (es) Nuevos derivados carboxamidas ciclicos sustituidos por carboxi.
ES2160240T3 (es) Benzamidas para el tratamiento de desordenes neurodegenerativos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 946548

Country of ref document: ES